Testoderm TTS CIII
Company: AlzaApproval Status: Approved December 1997
Treatment for: testosterone deficiency
Areas: Diabetes / Endocrinology
| General Information | Clinical Results |
General Information
Testoderm TTS CIII has been approved for men with testosterone deficiency. It is a transdermal patch that delivers a 5-mg dose of testosterone during a 24-hour period.
Clinical Results
Clinical Results: Clinical trials showed that application of the Testoderm patch maintained normal serum testosterone levels, with delivery comparable to the normal circadian pattern of testosterone secretion.
Testoderm TTS CIII Drug Information
The Testoderm Tts Ciii drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
